Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
about
PET Imaging of Epigenetic Influences on Alzheimer's DiseaseCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamChemical and neuropathological analyses of an Alzheimer's disease patient treated with solanezumabThe Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus reportImmune and myodegenerative pathomechanisms in inclusion body myositisAmyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI.Vitamin B1 (thiamine) and dementiaIncreased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis.Alzheimer Disease: Scientific Breakthroughs and Translational Challenges.Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.Machine Learning-based Individual Assessment of Cortical Atrophy Pattern in Alzheimer's Disease Spectrum: Development of the Classifier and Longitudinal Evaluation.Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
P2860
Q26776178-EAFBC569-3050-475F-8F71-5F09D53CFCD5Q28595520-067CEE83-3B0C-4209-9CEC-A91118AA29C1Q28828354-207B661F-C7D1-41C6-BE3C-6FB4826C4404Q31047635-FB592125-C23D-4817-95A9-AF8A1CF9DFAAQ33714693-BD54A77B-DF00-4A32-93C5-0928B4EC23F5Q33726628-1ACAA27D-E572-4BCB-B3AF-824DC8C01FBEQ33753870-6BBB1747-D91A-4481-BD87-DB9E99822D94Q36796489-79BFD235-C865-4C00-B11A-EA715566DCD5Q36840036-5C7923A5-CEEB-4749-B8B7-A70B4CABCAF4Q38657053-199EB3C4-556E-4FFF-9B94-134382D7AA42Q38675107-BEE5597F-4AF9-4811-8FE1-CAE2046C9C3AQ38683683-C8DA9779-26A5-4048-AEF2-CF32B32AE8FFQ38693441-90C55D15-E57F-4DC5-BEDA-80EBC698FE22Q38944065-51A1E9C5-AF02-4DA1-B1E3-FA459B555C2FQ39219904-958B0F9C-4FAE-4672-8DE3-12588E2AC667Q39644582-B120D904-27C9-4F22-8A4A-19777BD81B41Q47712192-A2569415-937E-4E45-ACDE-A2BAE8C8C7BEQ50420462-2D0FB5A4-DC76-4F5B-8561-1625A5C7D140Q51264997-730D12FF-238E-4041-9E3B-D3356C9F9C6DQ51766183-CEEB1A57-B955-4642-9801-C7B8CA95726C
P2860
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@ast
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@en
type
label
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@ast
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@en
prefLabel
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@ast
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@en
P2093
P2860
P50
P1433
P1476
Characterizing Apolipoprotein ...... mal β-Amyloid Peptide Plaques.
@en
P2093
Alex E Roher
Chera L Maarouf
Geidy Serrano
Richard J Caselli
Sarah E Monsell
Thomas J Montine
P2860
P304
P356
10.1001/JAMANEUROL.2015.1721
P407
P577
2015-08-24T00:00:00Z